InvestorsObserver
×
News Home

Where Does Aerie Pharmaceuticals Inc (AERI) Stock Fall in the Drug Manufacturers - Specialty & Generic Field After It Is Down -4.17% This Week?

Wednesday, October 20, 2021 10:46 AM | InvestorsObserver Analysts

Mentioned in this article

Where Does Aerie Pharmaceuticals Inc (AERI) Stock Fall in the Drug Manufacturers - Specialty & Generic Field After It Is Down -4.17% This Week?

The 45 rating InvestorsObserver gives to Aerie Pharmaceuticals Inc (AERI) stock puts it near the top of the Drug Manufacturers - Specialty & Generic industry. In addition to scoring higher than 85 percent of stocks in the Drug Manufacturers - Specialty & Generic industry, AERI’s 45 overall rating means the stock scores better than 45 percent of all stocks.

Overall Score - 45
AERI has an Overall Score of 45. Find out what this means to you and get the rest of the rankings on AERI!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes

InvestorsObserver

’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Aerie Pharmaceuticals Inc Stock Today?

Aerie Pharmaceuticals Inc (AERI) stock has fallen -5.78% while the S&P 500 has risen 0.44% as of 10:38 AM on Wednesday, Oct 20. AERI is down -$0.76 from the previous closing price of $13.16 on volume of 241,322 shares. Over the past year the S&P 500 has risen 31.85% while AERI has risen 35.96%. AERI lost -$3.61 per share the over the last 12 months. Click Here to get the full Stock Report for Aerie Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App